Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Scientific Reports|November 12, 2017
Diagnostic value of blood-derived microRNAs for schizophrenia: results of a meta-analysis and validationSha Liu, Fuquan Zhang, Xijin Wang, et al.
Journal of Pineal Research|August 1, 2024
KARS Mutations Impair Brain Myelination by Inducing Oligodendrocyte Deficiency: One Potential Mechanism and Improvement by MelatoninLijia Yu, Zhilin Chen, Xiaolong Zhou, et al.
General Psychiatry|December 24, 2021
The cost of obsessive-compulsive disorder (OCD) in China: a multi-center cross-sectional survey based on hospitalsWeili Yang, Zhen Tang, Xijin Wang, et al.
Open Life Sciences|April 28, 2026
Lower serum uric acid levels as a risk factor for depression in prodromal Parkinson's disease: a cohort studyKeke Liang, Yetong Ouyang, Bingyu Li, et al.
BMC Psychiatry|March 16, 2023
The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled studyYaxue Wu, Yanli Li, Weiye Liang, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 7, 2020
Influence of More Than 5 Years of Continuous Exposure to Antipsychotics on Cerebral Functional Connectivity of Chronic SchizophreniaQi Miao, Chengcheng Pu, Zhijiang Wang, et al.
International Immunopharmacology|May 20, 2026
Role of ROCK-associated inflammation and redox imbalance in Parkinson's disease dyskinesia: evidence from animal and patient studiesMeihua Wang, Tao Li, Keke Liang, et al.
Schizophrenia Research|May 6, 2014
Disrupted resting-state functional connectivity in minimally treated chronic schizophreniaXijin Wang, Mingrui Xia, Yunyao Lai, et al.
Frontiers in Psychiatry|September 5, 2022
Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing SurveillanceHaishan Wu, Xijin Wang, Xuejun Liu, et al.
BMC Psychiatry|February 22, 2023
Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillanceQijing Bo, Xijin Wang, Xuejun Liu, et al.
Pageof 7